Výsledky vyhledávání - "Deborah Yarbrough"

The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial

Autor: David P. Yarnall, Stephen Haneline, Brenda L. Plassman, Carl Chiang, Kathleen A. Welsh-Bohmer, Grant Runyan, Stephen Brannan, Janet O'Neil, Patrick Harrigan, Craig Metz, Ann M. Saunders, Eric Lai, Daniel K. Burns, Meredith Culp, Scott S. Sundseth, Sridevi Ponduru, Michael W. Lutz, Deborah Yarbrough

Publikováno v: Alzheimer's & Dementia : Translational Research & Clinical Interventions

Introduction Alzheimer's disease (AD) is a continuum with neuropathologies manifesting years before clinical symptoms; thus, AD research is attempting to identify more disease-modifying approaches to test treatments administered before full disease e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc4310e7822da76559ba1786c6b1cdc0
http://europepmc.org/articles/PMC6838537

Zobrazit plný text záznamu

P1‐050: ADJUDICATING MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE AS A NOVEL ENDPOINT EVENT IN THE TOMMORROW STUDY: A DELAY‐OF‐ONSET PHASE 3 CLINICAL TRIAL

Publikováno v: Alzheimer's & Dementia. 14

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b8b25c12f0950d6df9e36baa78c8eaab
https://doi.org/10.1016/j.jalz.2018.06.051

Zobrazit plný text záznamu

P4‐383: Characterization of the Screened Population for the Tommorrow Study: a Pharmacogenetics‐Supported Clinical Trial to Delay the Onset of Mild Cognitive Impairment Due to Alzheimer’S Disease

Autor: Deborah Yarbrough, Carl Chiang, Ferenc Martenyi, Stephen Haneline, David Yarnall, Brenda L. Plassman, Eric C. Lai, Ann M. Saunders, Daniel K. Burns, Janet O'Neil, Allen D. Roses, Craig A. Metz, Michael W. Lutz, Meredith Culp, Kathleen A. Welsh-Bohmer, Grant Runyan, Patrick Harrigan

Publikováno v: Alzheimer's & Dementia. 12

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f63ba19fd6d256b2928f44f5e8490067
https://doi.org/10.1016/j.jalz.2016.07.129

Zobrazit plný text záznamu

P2‐083: Progress in the tommorrow study: A pharmacogenetics supported clinical trial to delay onset of mild cognitive impairment due to Alzheimer's disease with low‐dose pioglitazone

Autor: Donna G. Crenshaw, Eric Lai, Ann M. Saunders, Michael W. Lutz, Craig A. Metz, Stephen Brannan, Meredith Culp, Kathleen A. Welsh-Bohmer, Allen D. Roses, Kumar Budur, Carl Chiang, David Yarnall, Daniel K. Burns, Deborah Yarbrough, Grant Runyan, Janet O'Neil

Publikováno v: Alzheimer's & Dementia. 11

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::68544bb29714ad374291e2f5aabb6ed8
https://doi.org/10.1016/j.jalz.2015.06.620

Zobrazit plný text záznamu

P4‐073: A PHARMACOGENETICS‐SUPPORTED CLINICAL TRIAL TO DELAY ONSET OF MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE USING LOW‐DOSE PIOGLITAZONE: AN UPDATE ON THE TOMORROW STUDY

Autor: David P. Yarnall, Marcia Cyganowski, Kumar Budur, Michael W. Lutz, Grant Runyan, Daniel K. Burns, Ann M. Saunders, Carl Chiang, Stephen Brannan, Kathleen A. Welsh-Bohmer, Eric Lai, Janet O'Neil, Allen D. Roses, Craig A. Metz, Donna G. Crenshaw, Deborah Yarbrough

Publikováno v: Alzheimer's & Dementia. 10

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::77dd6bb400bf45d77da9d20cded83ead
https://doi.org/10.1016/j.jalz.2014.05.1588

Zobrazit plný text záznamu

P4‐269: A pharmacogenetic‐supported clinical trial to delay onset of mild cognitive impairment (MCI) due to Alzheimer's disease (AD)

Autor: Deborah Yarbrough, Michael W. Lutz, Carl Chiang, Sheila Talbott, Daniel K. Burns, Craig A. Metz, Donna G. Crenshaw, Kathleen A. Welsh-Bohmer, Stephen Brannan, Allen D. Roses, Ann M. Saunders

Publikováno v: Alzheimer's & Dementia. 8

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::861c81b293fc12e4c97ce7e4dd219164
https://doi.org/10.1016/j.jalz.2013.08.050

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání